Clinical Trial Update: Gentamicin Therapy for Recessive Dystrophic Epidermolysis Bullosa (RDEB) Nonsense Mutation Patients [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial investigating gentamicin therapy for nonsense mutations in Recessive Dystrophic Epidermolysis Bullosa has completed with results posted…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Recessive Dystrophic Epidermolysis Bullosa

Drugs mentioned

• Gentamicin (gentamicin)

Snippet

Sponsor: University of Southern California | Conditions: Recessive Dystrophic Epidermolysis Bullosa | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2019-08-14